Successful treatment of endogenous depression with alprazolam in a patient with recent cardiac disease: case report.
Alprazolam, a triazolobenzodiazepine, was successfully used to treat a patient with recent cardiac disease who presented with DST-positive endogenous depression. The relative absence of cardiotoxic effects warrants the consideration of this medication in cardiac patients with concurrent anxiety and/or depression.
D000525:Alprazolam; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000150:complications / Q000188:drug therapy; D001569:Benzodiazepines / Q000627:therapeutic use*; D003327:Coronary Disease / Q000150:complications; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006331:Heart Diseases / Q000150:complications*; D006801:Humans; D008875:Middle Aged
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D000525:Alprazolam